Friday 6 November 2026
Export IOSP’s income statement to Excel — free account
Innospec Inc.
IOSP Basic Materials Specialty Chemicals
Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024.
- Revenue
- +7.17%
- EPS
- +146.7%
- Free cash flow
- −88.7%
Quarter to September 2026, against a year earlier
77.67
1.46
−1.85%
Follow IOSP
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.35 | 15.87 | 16.58 | 16.80 |
P/S ratio |
1.07 | 1.01 | 1.09 | 1.25 | |
P/FCF ratio |
29.80 | 32.89 | 39.02 | 64.68 | |
P/Operating CF |
31.53 | 102.79 | 278.58 | 134.93 | |
P/B ratio |
1.43 | 1.34 | 1.48 | 1.70 | |
Price to Tangible BV |
2.20 | 2.05 | 2.26 | 2.55 | |
EV/Sales |
0.92 | 0.86 | 0.96 | 1.13 | |
EV/EBITDA |
9.44 | 9.28 | 10.43 | 11.48 | |
EV/Operating CF |
11.81 | 12.08 | 14.30 | 20.64 | |
EV/FCF |
25.56 | 28.03 | 34.58 | 58.33 | |
Quick Ratio |
1.76 | 1.92 | 1.79 | 1.84 | |
Current Ratio |
2.79 | 2.98 | 2.78 | 2.95 | |
Net Debt/EBITDA |
(7.88) | (6.23) | (5.03) | (4.91) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.00 | 1.00 | 1.01 | 1.03 | |
Operating CF/Net income |
1.27 | 0.58 | 0.23 | 0.55 | |
Capex/Depreciation |
2.11 | (1.38) | (1.65) | (1.62) | |
Research and Development Expense of Revenue |
2.41% | 2.91% | 2.89% | 3.55% | |
Selling, General and Administrative Expense of Revenue |
15.21% | 17.32% | 17.16% | 15.14% | |
Intangible Assets out of Total Assets |
0.25 | 0.26 | 0.25 | 0.25 | |
Share Based Compensation of Revenue |
0.68% | 0.35% | 0.45% | 0.30% | |
Graham Net Nets |
0.27 | 0.29 | 0.26 | 0.24 | |
Graham Number |
75.11 | 75.16 | 77.82 | 84.57 | |
Earnings Yield |
6.11% | 6.30% | 6.03% | 5.95% | |
Free Cash Flow Yield |
3.36% | 3.04% | 2.56% | 1.55% | |
Revenue per Share |
18.31 | 18.29 | 19.94 | 19.23 | |
Operating CF per Share |
2.43 | 0.71 | 0.29 | 0.71 | |
Capex per Share |
(0.82) | (0.55) | (0.67) | (0.63) | |
Free Cash Flow per Share |
1.60 | 0.16 | (0.38) | 0.07 | |
Cash per Share |
11.76 | 11.67 | 10.15 | 10.23 | |
Shareholders Equity per Share |
53.57 | 54.58 | 54.82 | 56.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
53.57 | 54.58 | 54.82 | 56.04 | |
Free Cash Flow |
39.90 | 3.90 | (9.30) | 1.80 | |
Working Capital |
644.50 | 664.30 | 656.60 | 683.20 | |
Capital Expenditures |
(20.50) | (13.70) | (16.50) | (15.60) | |
Net Current Asset Value |
505.10 | 531.50 | 529.50 | 558.10 | |
EV/EBIT |
12.61 | 12.48 | 13.79 | 12.86 | |
Capex to Sales |
0.05 | 0.03 | 0.03 | 0.03 | |
Price to Operating Income |
14.71 | 14.65 | 15.56 | 14.26 | |
| Other line items | |||||
Average Receivables |
342.00 | 348.85 | 372.35 | 372.55 | |
Average Payables |
169.25 | 154.00 | 159.40 | 163.30 | |
Average Inventory |
315.15 | 318.45 | 337.05 | 353.50 | |
Average Assets |
1,783.55 | 1,797.20 | 1,826.15 | 1,828.00 | |
Average Common Equity |
1,274.50 | 1,308.95 | 1,326.25 | 1,341.60 |
Columns are period end dates · fundamentals updated 6 Nov 2026